Related Experiment Video
Updated: May 25, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
Luksika Jiramonai1,2, Xing-Jie Liang1,2, Mengliang Zhu1,2
1Chinese Academy of Sciences (CAS), Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China.
Pharmaceutics
|February 26, 2025
Summary
Extracellular vesicles (EVs) are emerging as a powerful tool in cancer immunotherapy by overcoming tumor immune evasion. This review explores how EVs can be strategically used to enhance anti-tumor immune responses and improve cancer treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Nanomedicine
Background:
- Cancer immunotherapy leverages the immune system to target malignant cells.
- Tumors evade immune detection through mechanisms like immune checkpoint proteins.
- Extracellular vesicles (EVs) show promise in modulating immune responses against cancer.
Purpose of the Study:
- To provide a comprehensive overview of recent advances in using EVs for cancer immunotherapy.
- To discuss strategies for employing EVs to overcome tumor-induced immune tolerance.
- To explore the potential applications and challenges of EV-based nanomedicine in cancer treatment.
Main Methods:
- Review of current literature on extracellular vesicles (EVs) in cancer immunotherapy.
- Analysis of EV biogenesis, characteristics, and immune regulatory roles.
- Exploration of tumor microenvironment immune evasion strategies and EV-based countermeasures.
Main Results:
- EVs possess unique properties that enhance anti-tumor immune responses.
- Strategic use of EVs can overcome tumor-induced immune tolerance.
- EVs play a significant role in regulating the tumor microenvironment for improved immunotherapy.
Conclusions:
- Extracellular vesicles (EVs) represent a promising strategy for enhancing cancer immunotherapy.
- Further development of EV-based nanomedicine is crucial for improving treatment precision and efficacy.
- Addressing challenges in EV-based approaches will optimize cancer immunotherapy outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
01:30Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K